"The condition is named after Ian Bruce Sneddon (1915–1987), a British dermatologist who published a seminal case series describing the condition in 1965 6."
"There is no effective treatment to control disease progression but long-term antiplatelet therapy and anticoagulation are commonly used in cases with cerebral manifestations."